Article
Monoamine oxidase-A (MAO-A) low-expression variants and increased risk of Plasmodium vivax malaria relapses.
The Journal of antimicrobial chemotherapy - 1 Aug 2024
Puça Maria Carolina Silva De Barros, Rodrigues Danielle Fonseca, Salazar Yanka Evellyn Alves Rodrigues, Louzada Jaime, Fontes Cor Jesus Fernandes, Daher André, Pereira Dhélio Batista, Fernandes Vieira José Luiz, Carvalho Luzia Helena, Alves de Brito Cristiana Ferreira, Gil José Pedro, Nobrega de Sousa Tais
Abstract excerpt
OBJECTIVES: Primaquine is essential for the radical cure of Plasmodium vivax malaria and must be metabolized into its bioactive metabolites. Accordingly, polymorphisms in primaquine-metabolizing enzymes can impact the treatment efficacy. This pioneering study explores the influence of monoamine oxidase-A (MAO-A) on primaquine metabolism and its impact on malaria relapses. METHODS: Samples from 205 patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
